Title 21

PART 7

Part 7 - Enforcement Policy

PART 7 - ENFORCEMENT POLICY Authority:21 U.S.C. 321-393; 42 U.S.C. 241, 262, 263b-263n, 264. Source:42 FR 15567, Mar. 22, 1977, unless otherwise noted.

21:1.0.1.1.7.1SUBPART A
Subpart A - General Provisions
21:1.0.1.1.7.1.63.1SECTION 7.1
   7.1 Scope.
21:1.0.1.1.7.1.63.2SECTION 7.3
   7.3 Definitions.
21:1.0.1.1.7.1.63.3SECTION 7.12
   7.12 Guaranty.
21:1.0.1.1.7.1.63.4SECTION 7.13
   7.13 Suggested forms of guaranty.
21:1.0.1.1.7.2SUBPART B
Subpart B [Reserved]
21:1.0.1.1.7.3SUBPART C
Subpart C - Recalls (Including Product Corrections) - Guidance on Policy, Procedures, and Industry Responsibilities
21:1.0.1.1.7.3.63.1SECTION 7.40
   7.40 Recall policy.
21:1.0.1.1.7.3.63.2SECTION 7.41
   7.41 Health hazard evaluation and recall classification.
21:1.0.1.1.7.3.63.3SECTION 7.42
   7.42 Recall strategy.
21:1.0.1.1.7.3.63.4SECTION 7.45
   7.45 Food and Drug Administration-requested recall.
21:1.0.1.1.7.3.63.5SECTION 7.46
   7.46 Firm-initiated recall.
21:1.0.1.1.7.3.63.6SECTION 7.49
   7.49 Recall communications.
21:1.0.1.1.7.3.63.7SECTION 7.50
   7.50 Public notification of recall.
21:1.0.1.1.7.3.63.8SECTION 7.53
   7.53 Recall status reports.
21:1.0.1.1.7.3.63.9SECTION 7.55
   7.55 Termination of a recall.
21:1.0.1.1.7.3.63.10SECTION 7.59
   7.59 General industry guidance.
21:1.0.1.1.7.4SUBPART D
Subpart D [Reserved]
21:1.0.1.1.7.5SUBPART E
Subpart E - Criminal Violations
21:1.0.1.1.7.5.63.1SECTION 7.84
   7.84 Opportunity for presentation of views before report of criminal violation.
21:1.0.1.1.7.5.63.2SECTION 7.85
   7.85 Conduct of a presentation of views before report of criminal violation.
21:1.0.1.1.7.5.63.3SECTION 7.87
   7.87 Records related to opportunities for presentation of views conducted before report of criminal violation.